
Cheryl A. Grandinetti, PharmD
Articles by Cheryl A. Grandinetti, PharmD


Pneumonia and influenza together represent the seventh leading cause of death in the United States. Pharmacists can influence care by ensuring that appropriate therapy is initiated quickly and closely monitoring patients.

Tuberculosis remains a major global health concern?it is important for the pharmacist to focus on patient medication adherence to avoid drug resistance.

Pharmacists can improve care of patients with hepatitis B or C through recommendations, monitoring, and education.


Dr. Grandinetti is a senior clinical research pharmacist at the National Cancer Institute, National Institutes of Health, Rockville, Md. The views expressed are those of the author and not those of any government agency.

The views expressed are those of the author and not those of any government agency.
Latest Updated Articles
- Inflammatory Bowel Disease
Published: May 15th 2009 | Updated:
- Continuity of Care: Pneumonia: Targeting Treatments and Monitoring the Response
Published: November 1st 2008 | Updated:
- Treatment Goals for Drug-Resistant Tuberculosis
Published: November 1st 2008 | Updated:
- Helping Hepatitis Patients Manage Their Disease
Published: February 1st 2008 | Updated:
- Continuity of Care: Treating the Cataract Patient
Published: January 1st 2008 | Updated:
- PEP for HIV, Hepatitis B, and Hepatitis C May Reduce Risk
Published: August 1st 2007 | Updated: